Publication | Closed Access
The Cost Effectiveness of Genetic Testing for CYP2C19 Variants to Guide Thienopyridine Treatment in Patients with Acute Coronary Syndromes
40
Citations
22
References
2012
Year
Genetic TestingCardiovascular DiseaseGenetic EpidemiologyCardiovascular GeneticsPharmacogenomicsPharmacotherapyCost EffectivenessPublic HealthMedicineCardiologyAcute Coronary SyndromesEpidemiologyCoronary Artery DiseaseAcute Myocardial InfarctionMyocardial Infarction
| Year | Citations | |
|---|---|---|
Page 1
Page 1